Dashboard
Manage Tickers

TPST Tempest Therapeutics, Inc.

Nasdaq tempesttx.com


$ 4.84 $ -3.76 (-43.69 %)    

Wednesday, 19-Nov-2025 14:23:22 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 597.70 $ 0.64 (0.11 %)
DIA $ 460.50 $ -1.03 (-0.22 %)
SPY $ 660.86 $ 0.06 (0.01 %)
TLT $ 89.13 $ -0.09 (-0.1 %)
GLD $ 374.65 $ -3.13 (-0.83 %)
$ 9.24
$ 8.60
$ 4.84 x 1,873
$ 4.85 x 11
$ 4.51 - $ 8.60
$ 5.35 - $ 13.65
26,563
na
41.03M
$ 2.74
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 03-27-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-19-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-22-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 05-13-2022 03-31-2022 10-Q
16 03-29-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-13-2021 03-31-2021 10-Q
20 03-29-2021 12-31-2020 10-K
21 11-09-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 03-11-2020 12-31-2019 10-K
25 11-13-2019 09-30-2019 10-Q
26 08-12-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 04-01-2019 12-31-2018 10-K
29 11-09-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-03-2018 03-31-2018 10-Q
32 03-15-2018 12-31-2017 10-K
33 11-02-2017 09-30-2017 10-Q
34 08-03-2017 06-30-2017 10-Q
35 05-09-2017 03-31-2017 10-Q
36 03-02-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-04-2016 06-30-2016 10-Q
39 05-05-2016 03-31-2016 10-Q
40 02-26-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

crude-oil-falls-over-2-lowes-shares-gain-after-q3-results
Crude Oil Falls Over 2%; Lowe's Shares Gai...
11/19/2025 17:58:53

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
11/19/2025 17:06:03

nasdaq-gains-over-100-points-target-trims-earnings-forecast
Nasdaq Gains Over 100 Points; Target Trims...
11/19/2025 16:42:16

why-tempest-therapeutics-tpst-stock-is-down-45-today
Why Tempest Therapeutics (TPST) Stock Is D...
11/19/2025 16:33:10

Tempest Therapeutics shares fell Wednesday after the announcement of an all-stock acquisition of dual-CAR T programs from Facto...

Core News & Articles
Tempest Announces Matt Angel To Assume Rol...
11/19/2025 15:00:48

Matt Angel, Ph.D.Dr. Matt Angel is an experienced biotechnology executive with expertise in leading lean cell therapy companies...

tempest-therapeutics-shares-resume-trade
Tempest Therapeutics Shares Resume Trade
11/19/2025 14:58:41

tempest-therapeutics-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down--3496
Tempest Therapeutics Shares Halted On Circ...
11/19/2025 14:57:35

update-tempest-to-acquire-factors-dual-car-t-programs-in-all-stock-deal-issuing-8268495-shares-stockholders-will-be-entitled-to-receive-1-common-stock-warrant-for-every-share-of-common-stock-held-and-outstanding-at-a-date-immediately-prior-to-the-closing-warrants-will-be-immediately-exercisable-with-an-initial-exercise-price-equal-to-1848-and-will-expire-5-years-from-the-issuance-date
UPDATE: Tempest To Acquire Factor's Dual-C...
11/19/2025 14:57:12

Tempest will issue 8,268,495 shares of its common stock, par value $0.001 per share ("Common Stock"), to an affiliate o...

tempest-therapeutics-signs-agreements-to-acquire-certain-dual-targeting-chimeric-antigen-receptor-t-programs-from-factor-bioscience
Tempest Therapeutics Signs Agreements To A...
11/19/2025 14:04:57

Tempest Therapeutics, Inc. (Nasdaq: TPST) ("Tempest" or "the Company"), a clinical-stage biotechnology company ...

tempest-therapeutics-q3-eps-079-beats-327-estimate
Tempest Therapeutics Q3 EPS $(0.79) Beats ...
11/05/2025 13:34:07

Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of ...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
10/17/2025 21:07:13

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 21:13:45

tempest-therapeutics-q2-eps-207-beats-323-estimate
Tempest Therapeutics Q2 EPS $(2.07) Beats ...
08/11/2025 20:22:58

Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(2.07) per share which beat the analyst consensus estimate of ...

tempest-announces-46m-registered-direct-offering-of-common-stock-739000-shares-at-625-per-share
Tempest Announces $4.6M Registered Direct ...
06/11/2025 12:11:03

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/11/2025 12:07:40

why-circle-internet-group-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket
Why Circle Internet Group Shares Are Tradi...
06/09/2025 12:46:39

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
06/09/2025 12:08:42

tempest-announces-it-has-received-orphan-drug-designation-from-european-medicines-agency-for-its-amezalpat-for-treatment-of-patients-with-hepatocellular-carcinoma
Tempest Announces It Has Received Orphan D...
06/05/2025 12:08:01

EMA Orphan Drug Designation (ODD) builds on U.S. Food & Drug Administration (FDA) ODD and Fast Track Designation, underscor...

tempest-therapeutics-q1-eps-316-beats-371-estimate
Tempest Therapeutics Q1 EPS $(3.16) Beats ...
05/13/2025 20:45:29

Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(3.16) per share which beat the analyst consensus estimate of ...

tempest-presents-new-amezalpat-moa-data-supporting-its-potential-as-novel-cancer-treatment-at-the-2025-aacr-annual-meeting
Tempest Presents New Amezalpat MOA Data Su...
04/28/2025 20:07:01

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION